Drug profile · INN
riociguat
ADEMPAS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
riociguat (ADEMPAS) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN riociguat
Brand ADEMPAS
Route ORAL
Formulation TABLET
ATC code C02KX05
Originator Teva Pharma GmbH
Frequently asked questions
What is riociguat?
riociguat (ADEMPAS) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for riociguat?
ADEMPAS is a marketed brand name for riociguat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of riociguat?
riociguat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.